Nasal delivery of octreotide: Absorption enhancement by particulate carrier systems

International Journal of Pharmaceutics

Volumn 139, Issue 1-2, 1996, Pages 25-32

  Oechslein, Christine R ^a,b   Fricker, Gert ^b,c   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Sandoz Pharma Ltd   (Switzerland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Ca2+ adsorption; Nasal absorption; Particulate carrier; Peptide transport; Tight junctions

Indexed keywords

ALGINIC ACID; CELLULOSE; CHITOSAN; DRUG CARRIER; HETASTARCH; MICROCRYSTALLINE CELLULOSE; OCTREOTIDE; PECTIN; SEPHADEX;

ADSORPTION; ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; CALCIUM BINDING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG FORMULATION; DRUG RELEASE; DRUG TRANSPORT; INTRANASAL DRUG ADMINISTRATION; MALE; NONHUMAN; NOSE MUCOSA; PHARMACOKINETICS; PRIORITY JOURNAL; RAT;

EID: 0030576623     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04569-3     Document Type: Article

References (23)

1. Almeida, A.J., Alpar, H.O. and Brown, M.R.W., Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(-L-)lactic acid microspheres in rats, rabbits and guinea pigs. J. Pharm. Pharmacol., 45 (1993) 198-203.
2. Artursson, P. and Magnusson, C., Epithelial transport of drugs in cell culture. J. Pharm. Sci., 79 (1989) 595-600.
3. Björk. E., Isaksson, U., Edman and Artusson, P., Starch microspheres induce pulsatile delivery of drugs and peptides across the epithelial barrier by reversible separation of the tight junctions. J. Drug Targ., 2 (1995) 501-507.
4. Edman, P., Björk, E., Isaksson, U. and Artursson, P., Starch microspheres enhance insulin absorption across epithelial cells by affecting the integrity of tight junctions. Proc. Dispos. Deliv. Pept. Drugs. Leiden, (1991) 15.
5. Edman, P. and Björk. E., Nasal delivery of peptide drugs. Adv. Drug Delivery Rev., 8 (1992) 165-177.
6. Edman, P., Björk, E. and Ryden, L., Microspheres as a nasal delivery system for peptide drugs. J. Contr. Rel., 21 (1992) 165-172.
7. Enslin, O., Measurement of liquid uptake of swellable and porous substances. Chem. Fabr., 6 (1933), 147-148.
8. + ion and albumin. Mod. Probl. Paediat., 19 (1977) 54-65.
9. Harris, A.G., Weeke, J., Christensen, S.E., Kaal, A., Illum, P. and Orskov, H., Preliminary results with sandostatin nasal powder in acromegalic patients. Metabolism. 41(9 Suppl. 2) (1992) 72-75.
10. Hirai, S., Yashiki, T. and Matsuzawa T., Absorption of drugs from the nasal mucosa of rats. Int. J. Pharm., 7 (1981) 317-325.
11. Illum, L., Drug delivery systems for nasal application. STP Pharma. 3 (1987) 594-598.
12. Illum, L., Jörgensen, H., Bisgaard, H., Krogsgaard, O. and Rossing, N., Bioadhesive microspheres as potential nasal drug delivery systems. Int. J. Pharm., 39 (1987) 189-199.
13. 2+ and cAMP. Adv. Drug Delivery. Rev., 11 (1993) 299-327.
14. Lee, V.H.L., Enzymatic barriers to peptide and protein absorption and the use of penetration enhancers to modify absorption. In: Davis, S.S., Illum, L. and Tomlinson, E. (Eds.). Delivery Systems for Peptide Drugs, Plenum Press, New York. 1986, pp. 87-107.
15. Marbach, P., Neufeld, M. and Pless. J., Clinical applications of somatostatin analogs. In: Patel. Y.C. and Tannenbaum, G.S. (Eds.). Somatostatin. Plenum Press. New York, 1985, pp. 339-353
16. Nagai, T., Mucosal adhesive dosage form. Med. Res. Rev., 6(2) (1986) 227-242.
17. Nagai, T., Nishimoto, Y., Nambu, N., Suzuki, Y. and Sekine, K., Powder dosage form of insulin for nasal administration. J. Contr. Rel., 1 (1984) 15-22.
18. Pereswetoff-Morath, L. and Edman, P., Dextran microspheres as a potential nasal drug delivery system for insulin - in vitro and in vivo properties. Int. J. Pharm., 124 (1995) 37-44.
19. Ryden, L. and Edman, P., Potential use of polymers and spheres as nasal drug delivery systems. Proceed. Intern. Symp. Contr. Rel. Bioact. Mater., 18 (1991) 495-496.
20. Schipper, N.G., Romeijn, S.G., Verhoef, J.C. and Merkus, F.W., Nasal insulin delivery with dimethyl-β-cyclodextrin as an absorption enhancer in rabbits.: powder more effective than liquid formulations. Pharm. Res., 10 (1993) 682-686.
21. Struszczyk, J., Microcrystalline Chitosan. Preparation and properties of microcrystalline chitosan. J. Appl. Polym. Sci., 33 (1987) 177-189.
22. Tomita, M., Shiga, M., Hayashi, M. and Awazu, S., Enhancement of colonic drug absorption by the paracellular permeation route. Pharm. Res., 5 (1988) 341-346.
23. Widdicombe, J.G. and Wells, U.M., Airway secretions. In: Proctor, D.F. and Andersen, R. (Ed.), The Nose, Elsevier, Amsterdam, 1982, p. 215.